PHARMA-SEILLES: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMA-SEILLES
Largest movements
- Financial fixed assets -€19,562
down €19,562 (-16.7%), from €117,227 to €97,665
- Cash +€7,691
up €7,691 (+33.6%), from €22,867 to €30,559
mainly Net result for the year (+€79,596) and Investment in fixed assets (net) (+€13,335)
- Receivables within one year -€5,605
down €5,605 (-9.3%), from €60,252 to €54,647
of which Trade receivables: -€5,855
- Stocks and contracts +€4,393
up €4,393 (+5.1%), from €86,406 to €90,799
- Short-term financial debts +€13,218
up €13,218 (+112.2%), from €11,782 to €25,000
- Reserves -€10,404
down €10,404 (-14.2%), from €73,066 to €62,662
- Other debts -€10,000
down €10,000 (-10.0%), from €100,000 to €90,000
- Gross operating margin +€5,845
up €5,845 (+3.6%), from €162,102 to €167,948
- Staff costs +€2,990
up €2,990 (+5.7%), from €52,084 to €55,074
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €294,377 | €283,948 | -€10,429 | -3.5% |
| Fixed assets | 21/28 | €123,140 | €106,149 | -€16,992 | -13.8% |
| Intangible fixed assets | 21 | €11 | €0 | -€11 | -100.0% |
| Tangible fixed assets | 22/27 | €5,903 | €8,484 | +€2,582 | +43.7% |
| Plant, machinery and equipment | 23 | €1,173 | €0 | -€1,173 | -100.0% |
| Furniture and vehicles | 24 | €4,730 | €8,484 | +€3,755 | +79.4% |
| Financial fixed assets | 28 | €117,227 | €97,665 | -€19,562 | -16.7% |
| Current assets | 29/58 | €171,237 | €177,799 | +€6,562 | +3.8% |
| Stocks and contracts in progress | 3 | €86,406 | €90,799 | +€4,393 | +5.1% |
| Stocks | 30/36 | €86,406 | €90,799 | +€4,393 | +5.1% |
| Amounts receivable within one year | 40/41 | €60,252 | €54,647 | -€5,605 | -9.3% |
| Trade receivables | 40 | €58,835 | €52,980 | -€5,855 | -10.0% |
| Other amounts receivable | 41 | €1,417 | €1,667 | +€250 | +17.6% |
| Cash at bank and in hand | 54/58 | €22,867 | €30,559 | +€7,691 | +33.6% |
| Deferred charges and accrued income | 490/1 | €1,711 | €1,794 | +€82 | +4.8% |
| Total equity and liabilities | 10/49 | €294,377 | €283,948 | -€10,429 | -3.5% |
| Equity | 10/15 | €91,816 | €81,412 | -€10,404 | -11.3% |
| Contributions | 10/11 | €18,750 | €18,750 | = | 0.0% |
| Reserves | 13 | €73,066 | €62,662 | -€10,404 | -14.2% |
| Distributable reserves | 133 | €73,066 | €62,662 | -€10,404 | -14.2% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €202,561 | €202,536 | -€25 | 0.0% |
| Amounts payable within one year | 42/48 | €202,561 | €202,536 | -€25 | 0.0% |
| Financial debts | 43 | €11,782 | €25,000 | +€13,218 | +112.2% |
| Credit institutions | 430/8 | €11,782 | €25,000 | +€13,218 | +112.2% |
| Trade debts | 44 | €70,520 | €69,133 | -€1,388 | -2.0% |
| Suppliers | 440/4 | €70,520 | €69,133 | -€1,388 | -2.0% |
| Taxes, remuneration and social security | 45 | €20,259 | €18,403 | -€1,855 | -9.2% |
| Taxes | 450/3 | €12,448 | €10,889 | -€1,559 | -12.5% |
| Remuneration and social security | 454/9 | €7,811 | €7,515 | -€296 | -3.8% |
| Other amounts payable | 47/48 | €100,000 | €90,000 | -€10,000 | -10.0% |
| Remuneration, social security and pensions | 62 | €52,084 | €55,074 | +€2,990 | +5.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,426 | €3,656 | -€770 | -17.4% |
| Other operating charges | 640/8 | €708 | €692 | -€15 | -2.2% |
| Non-recurring operating charges | 66A | - | €4,379 | +€4,379 | |
| Gross operating margin | 9900 | €162,102 | €167,948 | +€5,845 | +3.6% |
| Operating profit (loss) | 9901 | €104,885 | €104,146 | -€738 | -0.7% |
| Financial income | 75/76B | €3,502 | €3,174 | -€328 | -9.4% |
| Recurring financial income | 75 | €3,502 | €3,174 | -€328 | -9.4% |
| Financial charges | 65/66B | €1,406 | €174 | -€1,232 | -87.6% |
| Recurring financial charges | 65 | €1,406 | €174 | -€1,232 | -87.6% |
| Profit (loss) for the period before taxes | 9903 | €106,980 | €107,146 | +€166 | +0.2% |
| Income taxes | 67/77 | €27,631 | €27,550 | -€80 | -0.3% |
| Profit (loss) for the period | 9904 | €79,350 | €79,596 | +€246 | +0.3% |
| Profit (loss) for the period to be appropriated | 9905 | €79,350 | €79,596 | +€246 | +0.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.